J R Bebb1, L Leach, A Zaitoun, N Hand, D P Letley, R Thomas, J C Atherton. 1. Wolfson Centre for Digestive Diseases and Institute of Infections, Inflammation and Immunity, University Hospital Nottingham, Nottingham, UK. jamesbebb@doctors.org.uk
Abstract
BACKGROUND: The cadherin-catenin complex is the key component of the adherens junction in epithelial cells, and changes in this complex are implicated in gastric adenocarcinoma. Germline mutations in E-cadherin have been described in diffuse-type gastric adenocarcinoma. Helicobacter pylori infection is the first stage in gastric carcinogenesis. AIMS: To determine whether H pylori was associated with changes in the complex, and whether this was affected by virulence of the strain. METHODS: Epithelial cell lines were cultured with H pylori using the wild-type pathogenic and non-pathogenic strains and CagE null and VacA null isogenic mutants. Gastric biopsy specimens at endoscopy were obtained from patients with (n = 17) and without (n = 15) H pylori infection, and E-cadherin and beta-catenin expression was assessed by immunohistochemistry. H pylori was typed by polymerase chain reaction from these patients for CagE and VacA. RESULTS: In vitro studies showed that coculture with a pathogenic strain of H pylori led to disruption of epithelial junctional beta-catenin expression, but without evidence of nuclear translocation or signalling. This effect was independent of a functional Cag pathogenicity island and vacuolating activity, but dependent on live bacteria. No marked differences in beta-catenin or E-cadherin expression were seen in gastric biopsy specimens in patients with and without H pylori infection. CONCLUSION: Acute H pylori infection disrupts junctional beta-catenin in vitro, but chronic infection by H pylori has no effect on E-cadherin and beta-catenin expression, as seen in gastric biopsy specimens at the initial gastritis stage of the proposed Correa pathway of gastric carcinogenesis. A later effect at the later stages of atrophy or intestinal metaplasia cannot be ruled out.
BACKGROUND: The cadherin-catenin complex is the key component of the adherens junction in epithelial cells, and changes in this complex are implicated in gastric adenocarcinoma. Germline mutations in E-cadherin have been described in diffuse-type gastric adenocarcinoma. Helicobacter pyloriinfection is the first stage in gastric carcinogenesis. AIMS: To determine whether H pylori was associated with changes in the complex, and whether this was affected by virulence of the strain. METHODS: Epithelial cell lines were cultured with H pylori using the wild-type pathogenic and non-pathogenic strains and CagE null and VacA null isogenic mutants. Gastric biopsy specimens at endoscopy were obtained from patients with (n = 17) and without (n = 15) H pylori infection, and E-cadherin and beta-catenin expression was assessed by immunohistochemistry. H pylori was typed by polymerase chain reaction from these patients for CagE and VacA. RESULTS: In vitro studies showed that coculture with a pathogenic strain of H pylori led to disruption of epithelial junctional beta-catenin expression, but without evidence of nuclear translocation or signalling. This effect was independent of a functional Cag pathogenicity island and vacuolating activity, but dependent on live bacteria. No marked differences in beta-catenin or E-cadherin expression were seen in gastric biopsy specimens in patients with and without H pylori infection. CONCLUSION: Acute H pylori infection disrupts junctional beta-catenin in vitro, but chronic infection by H pylori has no effect on E-cadherin and beta-catenin expression, as seen in gastric biopsy specimens at the initial gastritis stage of the proposed Correa pathway of gastric carcinogenesis. A later effect at the later stages of atrophy or intestinal metaplasia cannot be ruled out.
Authors: E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin Journal: Nature Date: 2000-03-23 Impact factor: 49.962
Authors: E Kapiteijn; G J Liefers; L C Los; E K Kranenbarg; J Hermans; R A Tollenaar; Y Moriya; C J van de Velde; J H van Krieken Journal: J Pathol Date: 2001-09 Impact factor: 7.996
Authors: Y Hirata; S Maeda; Y Mitsuno; M Akanuma; Y Yamaji; K Ogura; H Yoshida; Y Shiratori; M Omata Journal: Infect Immun Date: 2001-06 Impact factor: 3.441
Authors: J Yu; M P Ebert; S Miehlke; H Rost; U Lendeckel; A Leodolter; M Stolte; E Bayerdörffer; P Malfertheiner Journal: Gut Date: 2000-05 Impact factor: 23.059
Authors: M Asahi; T Azuma; S Ito; Y Ito; H Suto; Y Nagai; M Tsubokawa; Y Tohyama; S Maeda; M Omata; T Suzuki; C Sasakawa Journal: J Exp Med Date: 2000-02-21 Impact factor: 14.307
Authors: Pamela M O'Connor; Tamia K Lapointe; Shannon Jackson; Paul L Beck; Nicola L Jones; Andre G Buret Journal: Infect Immun Date: 2011-08-08 Impact factor: 3.441
Authors: Alessandra F Gomes; Erick V Guimarães; Laís Carvalho; José R Correa; Leila Mendonça-Lima; Helene S Barbosa Journal: BMC Microbiol Date: 2011-05-18 Impact factor: 3.605
Authors: Mohammed Soutto; Judith Romero-Gallo; Uma Krishna; M Blanca Piazuelo; M Kay Washington; Abbes Belkhiri; Richard M Peek; Wael El-Rifai Journal: Oncotarget Date: 2015-07-20